Service profile
Actinium Pharmaceuticals
Develops targeted radiotherapies using actinium-225 isotope-based antibody-drug conjugates for treating blood cancers and solid tumors, with lead candidate Iomab-B in pivotal trials for conditioning prior to bone marrow transplant in acute myeloid leukemia patients.
About
What Actinium Pharmaceuticals is
Develops targeted radiotherapies using actinium-225 isotope-based antibody-drug conjugates for treating blood cancers and solid tumors, with lead candidate Iomab-B in pivotal trials for conditioning prior to bone marrow transplant in acute myeloid leukemia patients.
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
EnterpriseHealthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://actiniumpharmaceuticals.com |
| Status coverage | Public status page |
| Founded | 2000 |
| Headquarters | New York, New York, United States |
| Categories | Enterprise, Healthcare |
Loading offerings...
Alternatives
